Analytical Biological Services

Analytical Biological Services

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.9M

Overview

ABS Bio is a long-established, privately-held contract research service provider supporting the global biopharmaceutical industry. Its core business model revolves around offering essential research services—including human biospecimen supply, cell culture, biostorage, and custom assay development—which are critical for preclinical and diagnostic research. The company has recently signaled growth through strategic acquisition (Cureline, Inc.) and leadership renewal, positioning itself as a integrated partner in the drug discovery supply chain. Backed by multiple quality accreditations, ABS Bio leverages over 30 years of experience to provide reliable, scalable support to its clients.

DiagnosticsAntibodies

Technology Platform

Integrated service platform for human biospecimen procurement, biostorage, cell culture, and custom biological reagent production, supported by CAP/ISO quality systems.

Funding History

4
Total raised:$2.9M
Grant$2.3M
Grant$89K
Grant$99K
Grant$424K

Opportunities

The acquisition of Cureline significantly expands capabilities in high-demand oncology and rare disease biospecimens, opening new client segments.
Growing biopharma outsourcing trends and the rise of complex therapies (e.g., cell/gene) create sustained demand for reliable, quality-certified research services.

Risk Factors

Revenue is dependent on biopharma R&D spending, which can be cyclical.
Integrating the Cureline acquisition poses operational and cultural execution risks.
The company operates in a competitive CRO/services market with potential pricing pressure.

Competitive Landscape

ABS Bio competes in the fragmented contract research services market against large global CROs (e.g., LabCorp, Charles River), specialty biospecimen providers, and regional labs. Differentiation is based on niche expertise, quality certifications, client service, and the integrated suite of offerings post-Cureline acquisition.